Literature DB >> 9841480

Estrogen diminishes postischemic hydroxyl radical production.

N A McHugh1, G F Merrill, S R Powell.   

Abstract

Reperfusion of blood flow to an ischemic myocardium is imperative to survival; ironically, it may also manifest several pathophysiological conditions. The most important of these are reperfusion arrhythmias and tissue injury and/or death. The mechanisms involved in reperfusion arrhythmias remain to be fully elucidated; however, increasing evidence indicates that reperfusion-induced arrhythmias are a free radical-mediated phenomenon. Acute administration of conjugated equine estrogen to dogs attenuates ischemia- and reperfusion-induced arrhythmias. The cardioprotective effect of estrogens in postmenopausal women is well documented, and recent studies suggest that estrogens possess strong antioxidant properties, with equine estrogens most potent. In this study we show that administration of conjugated equine estrogen to fully anesthetized dogs abolishes the burst of .OH radicals typically produced on reperfusion of the myocardium. This indicates that estrogen might attenuate reperfusion-induced ventricular arrhythmias by virtue of its antioxidant properties, suggesting a novel cardioprotective effect of the hormone.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9841480     DOI: 10.1152/ajpheart.1998.274.6.H1950

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  8 in total

1.  Greater antiarrhythmic activity of acute 17beta-estradiol in female than male anaesthetized rats: correlation with Ca2+ channel blockade.

Authors:  K L Philp; M Hussain; N F Byrne; M J Diver; G Hart; S J Coker
Journal:  Br J Pharmacol       Date:  2006-08-29       Impact factor: 8.739

2.  Chronic effect of training on neutrophil functions in humans.

Authors:  K Tsukamoto; K Suzuki; K Machida
Journal:  Environ Health Prev Med       Date:  2001-04       Impact factor: 3.674

3.  Effect of 17 beta-estradiol on the brain damage and metabolic changes in rats.

Authors:  J Chen; T Lei; M F Ritz; A Mendelowitsch
Journal:  J Tongji Med Univ       Date:  2001

4.  Hormone replacement therapy is safe in women undergoing coronary artery bypass grafting.

Authors:  Nancy A Nussmeier; Christina Mora-Mangano; Manuel Fontes; Nanette M Schwann; Dennis T Mangano
Journal:  Tex Heart Inst J       Date:  2005

5.  Cardiac autonomic modulation by estrogen in female mice undergoing ambulatory monitoring and in vivo electrophysiologic testing.

Authors:  Samir Saba; Vladimir Shusterman; Irmute Usiene; Barry London
Journal:  Ann Noninvasive Electrocardiol       Date:  2004-04       Impact factor: 1.468

6.  Postischemic infusion of 17-beta-estradiol protects myocardial function and viability.

Authors:  Andrew M Terrell; Paul R Crisostomo; Troy A Markel; Meijing Wang; Aaron M Abarbanell; Jeremy L Herrmann; Daniel R Meldrum
Journal:  J Surg Res       Date:  2007-07-20       Impact factor: 2.192

7.  Experimentally-induced ventricular arrhythmias.

Authors:  Gary F Merrill
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2017-12-25

8.  Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist.

Authors:  Helen L Jeanes; Caroline Tabor; Darcey Black; Antwan Ederveen; Gillian A Gray
Journal:  J Endocrinol       Date:  2008-06       Impact factor: 4.286

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.